ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis

Ai, Gaoxiang; Huang, Ronglei; Xie, Jianhui; Zhong, Linjiang; Wu, Xiaoyan; Qin, Zehui; Su, Ziren; Chen, Jiannan; Yang, Xiaobo*; Dou, Yaoxing*广州中医药大学
Journal of Ethnopharmacology2023-1-30DOI: 10.1016/j.jep.2022.115775
7被引14阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Palmatine (Pal) is a major bioactive alkaloid originated from ancient Chinese herbal medicine Cortex Phellodendri Amurensis (CPA), which has long been applied to treat hyperuricemia (HUA)-related diseases. Pal possesses potent anti-inflammatory and anti-oxidant effects against metabolic diseases. However, its potential beneficial effect against PO (potassium oxonate)/HX (hypoxanthine)-induced HUA remains elusive.Aim of the study: This study aimed to investigate the potential pharmacological effect and mechanism of Pal on PO/HX-induced HUA in mice. Material and methods: A mouse model of HUA was established by co-administration of PO/HX once daily for 7 consecutive days. The HUA mice were orally given three doses (25, 50 and 100 mg/kg) of Pal daily for a week. Febuxostat (Feb, 5 mg/kg) was given as a positive control. At the scheduled termination of the experiment, the whole blood, liver and kidney were collected for subsequent analyses. The concentrations of uric acid (UA), creatinine (CRE) and blood urea nitrogen (BUN), and activities of adenosine deaminase (ADA) and xanthine oxidase (XOD) were evaluated. Histopathological alterations of the kidney were detected by H&E staining. The inflammatory and oxidative stress status was detected by assay kits. Additionally, key proteins involved in the urate transporter, Keap1-Nrf2 and TXNIP/NLRP3 signaling pathways were evaluated by immunohistochemistry and Western blotting. Finally, molecular docking was employed to probe the binding characteristics of Pal and target proteins Keap1, NLRP3, URAT1 and HO-1.Results: Administration of Pal substantially decreased the elevated kidney weight, lowered UA, CRE and BUN levels, and attenuated abnormal histopathological alterations. Meanwhile, treatment with Pal also dramatically lowered hepatic XOD and ADA activities. Besides, Pal treatment effectively mitigated the renal inflammatory and oxidative stress markers. Further mechanistic investigation indicated Pal distinctly downregulated the protein levels of GLUT9 and URAT1, while up-regulated the expression levels of OAT1 and ABCG2. Pal also restored Nrf2 activation, promoted subsequent expression of anti-oxidative enzymes, and downregulated the expressions of TXNIP, NLRP3, apoptosis-associated speck-like (ASC), caspase-1, IL-1 beta and IL-18. Molecular docking analysis also indicated Pal firmly bound with Keap1, NLRP3, URAT1 and HO-1.Conclusions: These findings indicated that Pal exhibited favorable anti-HUA effect via modulating the expressions of transporter-related proteins and suppressing XOD activity. Furthermore, Pal also alleviated HUA-induced kidney injury, which was at least partially related to restoring Keap1-Nrf2 pathway and inhibiting TXNIP/ NLRP3 inflammasome. Our investigation was envisaged to provide experimental support for the traditional application of CPA and CPA-containing classical herbal formulas in the management of HUA-related diseases and might provide novel dimension to the clinical application of Pal.

学科与关键词

关键词
PalmatineHyperuricemiaOxidative stressInflammationKeap-Nrf2 pathwayTXNIPNLRP3 inflammasome
相关
加载中…
  • Integrating network pharmacology and experimental validation to clarify the anti-hyperuricemia mechanism of cortex phellodendri in mice
    Xu, Lieqiang; Cheng, Juanjuan; Lu, Jieyi; Lin, Guoshu; Yu, Qiuxia; Li, Yucui; Chen, Jiannan; Xie, Jianhui; Su, Ziren*; Zhou, Qi*Frontiers in Pharmacology, 2022, 13: 964593.被引 4
  • Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-?B/NLRP3 and Nrf2 Pathways
    Cheng, Juan -Juan; Ma, Xing-Dong; Ai, Gao-Xiang; Yu, Qiu-Xia; Chen, Xiao-Ying; Yan, Fang; Li, Yu-Cui; Xie, Jian-Hui; Su, Zi-Ren*; Xie, Qing-Feng*Drug Design Development and Therapy, 2022, 16: 2119-2132.被引 20
  • Eupatilin inhibits xanthine oxidase in vitro and attenuates hyperuricemia and renal injury in vivo
    Xu, Guitao; Wu, Lele; Yang, Hongxuan; Liu, Tianfeng; Tong, Ying; Wan, Jiliang; Han, Bin; Zhou, Lin*; Hu, Xuguang*Food and Chemical Toxicology, 2024, 183: 114307.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2023-01-30
卷期
第 301 卷
页码
115775
DOI
10.1016/j.jep.2022.115775
语言
ENGLISH
成果收录
SCIE
资助标注
Key Project of State Key Laboratory of Dampness Syndrome of Chinese Medicine [SZ2021ZZ05, SZ2021ZZ03]; China Postdoctoral Science Foundation [2022M710910]; Guangdong Basic and Applied Basic Research Foundation [2021B1515140003]; National Natural Science Foundation of China [82074082]; Guangdong Natural Science Foundation [2021A1515011490]

作者

  • A

    Ai, Gaoxiang (第一作者)

    guangzhou univ chinese med

  • H

    Huang, Ronglei

    guangzhou univ chinese med

查看全部 10 位作者收起作者
  • X

    Xie, Jianhui

    2 · guangzhou univ chinese med

  • Z

    Zhong, Linjiang

    guangzhou univ chinese med

  • W

    Wu, Xiaoyan

    guangzhou univ chinese med

  • Q

    Qin, Zehui

    guangzhou univ chinese med

  • S

    Su, Ziren

    guangzhou univ chinese med

  • C

    Chen, Jiannan

    guangzhou univ chinese med

  • Y

    Yang, Xiaobo (通讯)

    2 · guangzhou univ chinese med

  • D

    Dou, Yaoxing (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417